Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 1,801–1,808 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
GH Research PLC GH1001 (GH001-BD-202) Bipolar II Disorder Phase 2a Ongoing Intranasal Psychiatric
GH Research PLC GH1001 (GH001-BD-202) Bipolar II Disorder Phase 2a Ongoing Intranasal Psychiatric
GH Research PLC GH1001 (GH001-PPD-203) Postpartum Depression Phase 2a Data Released Intranasal Psychiatric
Gilead Sciences Inc. Magrolimab Head and neck squamous cell carcinoma Phase 2 Trial Discontinued Intravenous Oncology
Gilead Sciences Inc. Magrolimab - (ENHANCE) Higher risk-Myelodysplastic Syndrome (MDS) Phase 3 Trial Discontinued Intravenous Hematology
Gilead Sciences Inc. Lenacapavir - (CALIBRATE) HIV Phase 2 Trial Completed Subcutaneous Anti-HIV
Gilead Sciences Inc. Magrolimab in Combination With Rituximab Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Phase 2 Trial Completed Intravenous Oncology
Gilead Sciences Inc. Magrolimab with Azacitidine Myelodyspastic syndrome and acute myeloid leukemia (AML) Phase 2 Trial Discontinued Intravenous Hematology